Oxidative stress and blood-brain barrier dysfunction under particular consideration of matrix metalloproteinases

Antioxidants and Redox Signaling

Volumn 15, Issue 5, 2011, Pages 1305-1323

  Lehner, Christine ^a,b   Gehwolf, Renate ^a,c   Tempfer, Herbert ^d   Krizbai, Istvan ^e   Hennig, Bernhard ^f   Bauer, Hans Christian ^a,d   Bauer, Hannelore ^a  

^a UNIVERSITY OF SALZBURG   (Austria)

^b Clinic for Sports Injuries and Trauma Surgery   (Austria)

^c Christian Doppler Klinik   (Austria)

^d PARACELSUS MEDICAL UNIVERSITY   (Austria)

^e INSTITUTE OF BIOCHEMISTRY   (Hungary)

^f UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; LIPID; MATRIX METALLOPROTEINASE; PROTEIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; DIABETES MELLITUS; DIABETIC RETINOPATHY; ENDOTHELIUM; ENZYME ACTIVATION; EPITHELIUM; HUMAN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; TUMOR; VASCULAR DISEASE;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CYTOKINES; ENDOTHELIAL CELLS; ENDOTHELIUM; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTES; MATRIX METALLOPROTEINASES; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TRANSCRIPTION, GENETIC;

EID: 79960749769     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2011.3923     Document Type: Review

References (196)

1. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, and Begley DJ. Structure and function of the blood-brain barrier. Neurobiol Dis 37: 13-25, 2010.
2. Adachi T, Fukushima T, Usami Y, and Hirano K. Binding of human xanthine oxidase to sulphated glycosaminoglycans on the endothelial-cell surface. Biochem J 289: 523-527, 1993. (Pubitemid 23042063)
3. Alexandre J, Batteux F, Nicco C, Chereau C, Laurent A, Guillevin L, Weill B, and Goldwasser F. Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo. Int J Cancer 119: 41-48, 2006.
4. Asahi M, Asahi K, Jung JC, del Zoppo GJ, Fini ME, and Lo EH. Role for matrix metalloproteinase 9 after focal cerebral ischemia: Effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab 20: 1681-1689, 2000.
5. Ayilavarapu S, Kantarci A, Fredman G, Turkoglu O, Omori K, Liu H, Iwata T, Yagi M, Hasturk H, and Van Dyke TE. Diabetes-induced oxidative stress is mediated by Ca2 +-independent phospholipase A2 in neutrophils. J Immunol 184: 1507-11515, 2010.
6. Balda MS and Matter K. Tight junctions at a glance. J Cell Sci 121: 3677-3682, 2008.
7. Balda MS and Matter K. Tight junctions and the regulation of gene expression. Biochim Biophys Acta 1788: 761-767, 2009.
8. Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, Lysko PG, and Feuerstein GZ. Tumor necrosis factoralpha. A mediator of focal ischemic brain injury. Stroke 28: 1233-1244, 1997. (Pubitemid 27248902)
9. Bauer AT, Burgers HF, Rabie T, and Marti HH. Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J Cereb Blood Flow Metab 30: 837-848, 2010.
10. Bauer H, Sonnleitner U, Lametschwandtner A, Steiner M, Adam H, and Bauer HC. Ontogenic expression of the erythroid-type glucose transporter (Glut 1) in the telencephalon of the mouse: Correlation to the tightening of the blood-brain barrier. Brain Res Dev Brain Res 86: 317-325, 1995.
11. Bauer H, Zweimueller-Mayer J, Steinbacher P, Lametschwandtner A, and Bauer HC. The dual role of zonula occludens (ZO) proteins. J Biomed Biotechnol 2010: 402593, 2010.
12. Bauer HC, Traweger A, Zweimueller-Mayer J, Lehner C, Tempfer H, Krizbai I, Wilhelm I, and Bauer H. New aspects of the molecular constituents of tissue barriers. J Neural Transm 118: 7-21, 2011.
13. Bazzoni G. The JAM family of junctional adhesion molecules. Curr Opin Cell Biol 15: 525-530, 2003. (Pubitemid 37176960)
14. Bazzoni G. Pathobiology of junctional adhesion molecules. Antioxid Redox Signal 15: 1221-1234, 2011.
15. Bergstrom P, Andersson HC, Gao Y, Karlsson JO, Nodin C, Anderson MF, Nilsson M, and Hammarsten O. Repeated transient sulforaphane stimulation in astrocytes leads to prolonged Nrf2-mediated gene expression and protection from superoxide-induced damage. Neuropharmacology 60: 343-353, 2011.
16. Betanzos A, Huerta M, Lopez-Bayghen E, Azuara E, Amerena J, and Gonzalez-Mariscal L. The tight junction protein ZO-2 associates with Jun, Fos and C/EBP transcription factors in epithelial cells. Exp Cell Res 292: 51-66, 2004. (Pubitemid 38058263)
17. Bhakat KK, Mantha AK, and Mitra S. Transcriptional regulatory functions of mammalian AP-endonuclease (APE1/Ref-1), an essential multifunctional protein. Antioxid Redox Signal 11: 621-638, 2009.
18. Blasig IE, Mertsch K, and Haseloff RF. Nitronyl nitroxides, a novel group of protective agents against oxidative stress in endothelial cells forming the blood-brain barrier. Neuropharmacology 43: 1006-1014, 2002. (Pubitemid 35341236)
19. Blasig IE, Bellmann C, Cording J, del Vecchio G, Zwanziger D, Huber O, and Haseloff RF. Occludin protein family: oxidative stress and reducing conditions. Antioxid Redox Signal 15: 1195-1219, 2011.
20. Boje KM and Lakhman SS. Nitric oxide redox species exert differential permeability effects on the blood-brain barrier. J Pharmacol Exp Ther 293: 545-550, 2000. (Pubitemid 30244106)
21. Bokoch GM and Zhao T. Regulation of the phagocyte NADPH oxidase by Rac GTPase. Antioxid Redox Signal 8: 1533-1548, 2006. (Pubitemid 44726329)
22. Bonello S, Zahringer C, BelAiba RS, Djordjevic T, Hess J, Michiels C, Kietzmann T, and Gorlach A. Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Arterioscler Thromb Vasc Biol 27: 755-761, 2007. (Pubitemid 46606703)
23. Bresgen N, Karlhuber G, Krizbai I, Bauer H, Bauer HC, and Eckl PM. Oxidative stress in cultured cerebral endothelial cells induces chromosomal aberrations, micronuclei, and apoptosis. J Neurosci Res 72: 327-333, 2003. (Pubitemid 36504701)
24. Bruce AJ, Boling W, Kindy MS, Peschon J, Kraemer PJ, Carpenter MK, Holtsberg FW, and Mattson MP. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med 2: 788-794, 1996. (Pubitemid 26225095)
25. Candelario-Jalil E, Yang Y, and Rosenberg GA. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience 158: 983-994, 2009.
26. Chan PH. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 21: 2-14, 2001. (Pubitemid 32036708)
27. Chen F, Ohashi N, Li W, Eckman C, and Nguyen JH. Disruptions of occludin and claudin-5 in brain endothelial cells in vitro and in brains of mice with acute liver failure. Hepatology 50: 1914-1923, 2009.
28. Coleman JD, Prabhu KS, Thompson JT, Reddy PS, Peters JM, Peterson BR, Reddy CC, and Vanden Heuvel JP. The oxidative stress mediator 4-hydroxynonenal is an intracellular agonist of the nuclear receptor peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta). Free Radic Biol Med 42: 1155-1164, 2007. (Pubitemid 46428510)
29. Collison KS, Parhar RS, Saleh SS, Meyer BF, Kwaasi AA, Hammami MM, Schmidt AM, Stern DM, and Al-Mohanna FA. RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs). J Leukoc Biol 71: 433-444, 2002.
30. Comporti M. Lipid peroxidation and biogenic aldehydes: From the identification of 4-hydroxynonenal to further achievements in biopathology. Free Radic Res 28: 623-635, 1998. (Pubitemid 28454255)
31. Cunningham LA, Wetzel M, and Rosenberg GA. Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia 50: 329-339, 2005. (Pubitemid 40780839)
32. Daneman R, Zhou L, Agalliu D, Cahoy JD, Kaushal A, and Barres BA. The mouse blood-brain barrier transcriptome: A new resource for understanding the development and function of brain endothelial cells. PLoS One 5: e13741, 2010.
33. de Vries HE, Witte M, Hondius D, Rozemuller AJ, Drukarch B, Hoozemans J, and van Horssen J. Nrf2-induced antioxidant protection: A promising target to counteract ROS-mediated damage in neurodegenerative disease? Free Radic Biol Med 45: 1375-1383, 2008.
34. del Zoppo GJ and Mabuchi T. Cerebral microvessel responses to focal ischemia. J Cereb Blood Flow Metab 23: 879-894, 2003. (Pubitemid 36959394)
35. Dong X, Song YN, Liu WG, and Guo XL. Mmp-9, a potential target for cerebral ischemic treatment. Curr Neuropharmacol 7: 269-275, 2009.
36. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95, 2002. (Pubitemid 34654215)
37. Ebnet K. Organization of multiprotein complexes at cell-cell junctions. Histochem Cell Biol 130: 1-20, 2008.
38. Engelhardt B and Sorokin L. The blood-brain and the blood-cerebrospinal fluid barriers: Function and dysfunction. Semin Immunopathol 31: 497-511, 2009.
39. Esterbauer H, Benedetti A, Lang J, Fulceri R, Fauler G, and Comporti M. Studies on the mechanism of formation of 4-hydroxynonenal during microsomal lipid peroxidation. Biochim Biophys Acta 876: 154-166, 1986. (Pubitemid 16011009)
40. 2+in rat liver microsomes. Biochem J 208: 129-140, 1982. (Pubitemid 13215400)
41. Evans JL, Goldfine ID, Maddux BA, and Grodsky GM. Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes. Endocr Rev 23: 599-622, 2002. (Pubitemid 35191625)
42. Felinski EA and Antonetti DA. Glucocorticoid regulation of endothelial cell tight junction gene expression: Novel treatments for diabetic retinopathy. Curr Eye Res 30: 949-957, 2005. (Pubitemid 43154689)
43. Felinski EA, Cox AE, Phillips BE, and Antonetti DA. Glucocorticoids induce transactivation of tight junction genes occludin and claudin-5 in retinal endothelial cells via a novel cis-element. Exp Eye Res 86: 867-878, 2008.
44. Festa A, Schmolzer B, Schernthaner G, and Menzel EJ. Differential expression of receptors for advanced glycation end products on monocytes in patients with IDDM. Diabetologia 41: 674-680, 1998. (Pubitemid 28261402)
45. Forster C, Silwedel C, Golenhofen N, Burek M, Kietz S, Mankertz J, and Drenckhahn D. Occludin as direct target for glucocorticoid-induced improvement of blood-brain barrier properties in a murine in vitro system. J Physiol 565: 475-486, 2005. (Pubitemid 40879596)
46. Frey T and Antonetti DA. Alterations to the blood-retinal barrier in diabetes: cytokines and reactive oxygen species. Antioxid Redox Signal 15: 1271-1284, 2011.
47. Fukumoto K, Takagi N, Yamamoto R, Moriyama Y, Takeo S, and Tanonaka K. Prostanoid EP1 receptor antagonist reduces blood-brain barrier leakage after cerebral ischemia. Eur J Pharmacol 640: 82-86, 2010.
48. Gao X, Xu X, Belmadani S, Park Y, Tang Z, Feldman AM, Chilian WM, and Zhang C. TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol 27: 1269-1275, 2007. (Pubitemid 46809414)
49. Gao X, Zhang H, Belmadani S, Wu J, Xu X, Elford H, Potter BJ, and Zhang C. Role of TNF-alpha-induced reactive oxygen species in endothelial dysfunction during reperfusion injury. Am J Physiol Heart Circ Physiol 295: H2242-2249, 2008.
50. Gasche Y, Soccal PM, Kanemitsu M, and Copin JC. Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain. Front Biosci 11: 1289-1301, 2006. (Pubitemid 43253422)
51. Gatenby RA and Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4: 891-899, 2004. (Pubitemid 39472955)
52. Gidday JM, Gasche YG, Copin JC, Shah AR, Perez RS, Shapiro SD, and Chan PH, Park TS. Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am J Physiol Heart Circ Physiol 289: H558-568, 2005. (Pubitemid 41129369)
53. Gilgun-Sherki Y, Melamed E, and Offen D. Oxidative stress induced-neurodegenerative diseases: The need for antioxidants that penetrate the blood-brain barrier. Neuropharmacology 40: 959-975, 2001. (Pubitemid 32530602)
54. Ginsberg MD. Neuroprotection for ischemic stroke: Past, present and future. Neuropharmacology 55: 363-389, 2008.
55. Gonzalez-Mariscal L, Tapia R, and Chamorro D. Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta 1778: 729-756, 2008. (Pubitemid 351317800)
56. González-Mariscal L, Quirós M, and Díaz- Coránguez M. ZO proteins and redox-dependent processes. Antioxid Redox Signal 15: 1235-1253, 2011.
57. Gorlach A, Brandes RP, Nguyen K, Amidi M, Dehghani F, and Busse R. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 87: 26-32, 2000. (Pubitemid 30456931)
58. Groemping Y, Lapouge K, Smerdon SJ, and Rittinger K. Molecular basis of phosphorylation-induced activation of the NADPH oxidase. Cell 113: 343-355, 2003. (Pubitemid 36556116)
59. Grosch S, Fritz G, and Kaina B. Apurinic endonuclease (Ref-1) is induced in mammalian cells by oxidative stress and involved in clastogenic adaptation. Cancer Res 58: 4410-4416, 1998. (Pubitemid 28450044)
60. Gu Z, Kaul M, Yan B, Kridel SJ, Cui J, Strongin A, Smith JW, Liddington RC, and Lipton SA. S-nitrosylation of matrix metalloproteinases: Signaling pathway to neuronal cell death. Science 297: 1186-1190, 2002. (Pubitemid 36193354)
61. Guillemot L, Paschoud S, Pulimeno P, Foglia A, and Citi S. The cytoplasmic plaque of tight junctions: A scaffolding and signalling center. Biochim Biophys Acta 1778: 601-613, 2008. (Pubitemid 351317804)
62. Gutierrez J, Ballinger SW, Darley-Usmar VM, and Landar A. Free radicals, mitochondria, and oxidized lipids: The emerging role in signal transduction in vascular cells. Circ Res 99: 924-932, 2006. (Pubitemid 44657795)
63. Halliwell B. Oxidative stress and cancer: Have we moved forward? Biochem J 401: 1-11, 2007. (Pubitemid 46115897)
64. Haorah J, Ramirez SH, Schall K, Smith D, Pandya R, and Persidsky Y. Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction. J Neurochem 101: 566-576, 2007. (Pubitemid 46525283)
65. Harhaj NS, Felinski EA, Wolpert EB, Sundstrom JM, Gardner TW, and Antonetti DA. VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability. Invest Ophthalmol Vis Sci 47: 5106-5115, 2006. (Pubitemid 46586418)
66. Hattori I, Takagi Y, Nakamura H, Nozaki K, Bai J, Kondo N, Sugino T, Nishimura M, Hashimoto N, and Yodoi J. Intravenous administration of thioredoxin decreases brain damage following transient focal cerebral ischemia in mice. Antioxid Redox Signal 6: 81-87, 2004. (Pubitemid 38063978)
67. Hawkins BT and Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 57: 173-185, 2005. (Pubitemid 41043883)
68. Heyworth PG and Badwey JA. Protein phosphorylation associated with the stimulation of neutrophils. Modulation of superoxide production by protein kinase C and calcium. J Bioenerg Biomembr 22: 1-26, 1990. (Pubitemid 20101586)
69. Hicks K, O'Neil RG, Dubinsky WS, and Brown RC. TRPCmediated actin-myosin contraction is critical for BBB disruption following hypoxic stress. Am J Physiol Cell Physiol 298: C1583-1593, 2010.
70. Hirata K, Ishida T, Penta K, Rezaee M, Yang E, Wohlgemuth J, and Quertermous T. Cloning of an immunoglobulin family adhesion molecule selectively expressed by endothelial cells. J Biol Chem 276: 16223-16231, 2001.
71. Hooper DC, Scott GS, Zborek A, Mikheeva T, Kean RB, Koprowski H, and Spitsin SV. Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. FASEB J 14: 691-698, 2000. (Pubitemid 30198568)
72. Houstis N, Rosen ED, and Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440: 944-948, 2006.
73. Huang CY, Fujimura M, Noshita N, Chang YY, and Chan PH. SOD1 down-regulates NF-kappaB and c-Myc expression in mice after transient focal cerebral ischemia. J Cereb Blood Flow Metab 21: 163-173, 2001. (Pubitemid 32143978)
74. Huppert J, Closhen D, Croxford A, White R, Kulig P, Pietrowski E, Bechmann I, Becher B, Luhmann HJ, Waisman A, and Kuhlmann CR. Cellular mechanisms of IL-17-induced blood-brain barrier disruption. FASEB J 24: 1023-1034, 2010.
75. Ikenouchi J, Furuse M, Furuse K, Sasaki H, and Tsukita S. Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells. J Cell Biol 171: 939-945, 2005. (Pubitemid 41815826)
76. Ishihara H, Kubota H, Lindberg RL, Leppert D, Gloor SM, Errede M, Virgintino D, Fontana A, Yonekawa Y, and Frei K. Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteins. J Neuropathol Exp Neurol 67: 435-448, 2008. (Pubitemid 351653535)
77. Ishrat T, Sayeed I, Atif F, Hua F, and Stein DG. Progesterone and allopregnanolone attenuate blood-brain barrier dysfunction following permanent focal ischemia by regulating the expression of matrix metalloproteinases. Exp Neurol 226: 183-190, 2010.
78. Islas S, Vega J, Ponce L, and Gonzalez-Mariscal L. Nuclear localization of the tight junction protein ZO-2 in epithelial cells. Exp Cell Res 274: 138-148, 2002.
79. Jian Liu K and Rosenberg GA. Matrix metalloproteinases and free radicals in cerebral ischemia. Free Radic Biol Med 39: 71-80, 2005. (Pubitemid 40733117)
80. Johnson JA, Johnson DA, Kraft AD, Calkins MJ, Jakel RJ, Vargas MR, and Chen PC. The Nrf2-ARE pathway: An indicator and modulator of oxidative stress in neurodegeneration. Ann NY Acad Sci 1147: 61-69, 2008.
81. Jung KA and Kwak MK. The Nrf2 system as a potential target for the development of indirect antioxidants. Molecules 15: 7266-7291, 2010.
82. Juric-Sekhar G, Zarkovic K, Waeg G, Cipak A, Zarkovic N. Distribution of 4-hydroxynonenal-protein conjugates as a marker of lipid peroxidation and parameter of malignancy in astrocytic and ependymal tumors of the brain. Tumori 95: 762-768, 2009.
83. Kago T, Takagi N, Date I, Takenaga Y, Takagi K, and Takeo S. Cerebral ischemia enhances tyrosine phosphorylation of occludin in brain capillaries. Biochem Biophys Res Commun 339: 1197-1203, 2006. (Pubitemid 41790589)
84. Kahles T, Luedike P, Endres M, Galla HJ, Steinmetz H, Busse R, Neumann-Haefelin T, and Brandes RP. NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke. Stroke 38: 3000-3006, 2007. (Pubitemid 350035696)
85. Kaneto H, Matsuoka TA, Katakami N, Kawamori D, Miyatsuka T, Yoshiuchi K, Yasuda T, Sakamoto K, Yamasaki Y, and Matsuhisa M. Oxidative stress and the JNK pathway are involved in the development of type 1 and type 2 diabetes. Curr Mol Med 7: 674-686, 2007. (Pubitemid 350201667)
86. Karlhuber GM, Bauer HC, and Eckl PM. Cytotoxic and genotoxic effects of 4-hydroxynonenal in cerebral endothelial cells. Mutat Res 381: 209-216, 1997. (Pubitemid 28015416)
87. Kean RB, Spitsin SV, Mikheeva T, Scott GS, and Hooper DC. The peroxynitrite scavenger uric acid prevents inflammatory cell invasion into the central nervous system in experimental allergic encephalomyelitis through maintenance of blood-central nervous system barrier integrity. J Immunol 165: 6511-6518, 2000.
88. 2 inhibition with apocynin worsens stroke outcome in aged rats. Brain Res 1292: 165-172, 2009.
89. Kern TS. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res 2007: 95103, 2007.
90. Kim HY and Han SH. Matrix metalloproteinases in cerebral ischemia. J Clin Neurol 2: 163-170, 2006.
91. Klaunig JE, Kamendulis LM, and Hocevar BA. Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol 38: 96-109, 2010.
92. Kobayashi M and Yamamoto M. Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid Redox Signal 7: 385-394, 2005. (Pubitemid 40279806)
93. Kohen R and Nyska A. Oxidation of biological systems: Oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 30: 620-650, 2002. (Pubitemid 36018731)
94. Kondo N, Nakamura H, Masutani H, and Yodoi J. Redox regulation of human thioredoxin network. Antioxid Redox Signal 8: 1881-1890, 2006. (Pubitemid 44726360)
95. Kopnin PB, Agapova LS, Kopnin BP, and Chumakov PM. Repression of sestrin family genes contributes to oncogenic Ras-induced reactive oxygen species up-regulation and genetic instability. Cancer Res 67: 4671-4678, 2007. (Pubitemid 46910172)
96. Kowluru RA, Koppolu P, Chakrabarti S, and Chen S. Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants. Free Radic Res 37: 1169-1180, 2003. (Pubitemid 37322195)
97. Kowluru RA, Tang J, and Kern TS. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 50: 1938-1942, 2001. (Pubitemid 33641616)
98. Krause G, Winkler L, Mueller SL, Haseloff RF, Piontek J, and Blasig IE. Structure and function of claudins. Biochim Biophys Acta 1778: 631-645, 2008.
99. Krizbai IA, Bauer H, Bresgen N, Eckl PM, Farkas A, Szatmari E, Traweger A, Wejksza K, and Bauer HC. Effect of oxidative stress on the junctional proteins of cultured cerebral endothelial cells. Cell Mol Neurobiol 25: 129-139, 2005. (Pubitemid 40558586)
100. Krueger M and Bechmann I. CNS pericytes: Concepts, misconceptions, and a way out. Glia 58: 1-10, 2010.
101. Kumar A, Mittal R, Khanna HD, and Basu S. Free radical injury and blood-brain barrier permeability in hypoxicischemic encephalopathy. Pediatrics 122: e722-727, 2008.
102. Lacraz G, Figeac F, Movassat J, Kassis N, Coulaud J, Galinier A, Leloup C, Bailbe D, Homo-Delarche F, and Portha B. Diabetic beta-cells can achieve self-protection against oxidative stress through an adaptive up-regulation of their antioxidant defenses. PLoS One 4: e6500, 2009.
103. Lakhan SE, Kirchgessner A, and Hofer M. Inflammatory mechanisms in ischemic stroke: Therapeutic approaches. J Transl Med 7: 97, 2009.
104. Liebner S, Cavallaro U, and Dejana E. The multiple languages of endothelial cell-to-cell communication. Arterioscler Thromb Vasc Biol 26: 1431-1438, 2006. (Pubitemid 44288966)
105. Liebner S, Fischmann A, Rascher G, Duffner F, Grote EH, Kalbacher H, and Wolburg H. Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme. Acta Neuropathol 100: 323-331, 2000. (Pubitemid 30456160)
106. Liu JF, Crepin M, Liu JM, Barritault D, and Ledoux D. FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway. Biochem Biophys Res Commun 293: 1174-1182, 2002. (Pubitemid 34681065)
107. Liu W, Hendren J, Qin XJ, Shen J, and Liu KJ. Normobaric hyperoxia attenuates early blood-brain barrier disruption by inhibiting MMP-9-mediated occludin degradation in focal cerebral ischemia. J Neurochem 108: 811-820, 2009.
108. Lochhead JJ, McCaffrey G, Quigley CE, Finch J, DeMarco KM, Nametz N, and Davis TP. Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation. J Cereb Blood Flow Metab 30: 1625-1636, 2010.
109. Lopez-Lazaro M. A new view of carcinogenesis and an alternative approach to cancer therapy. Mol Med 16: 144-153, 2010.
110. Machein MR and Plate KH. VEGF in brain tumors. J Neurooncol 50: 109-120, 2000. (Pubitemid 32166295)
111. Malemud CJ. Matrix metalloproteinases (MMPs) in health and disease: An overview. Front Biosci 11: 1696-1701, 2006. (Pubitemid 43253387)
112. Maritim AC, Sanders RA, and Watkins JB, 3rd. Diabetes, oxidative stress, and antioxidants: A review. J Biochem Mol Toxicol 17: 24-38, 2003. (Pubitemid 36410972)
113. Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, Bunz F, and Hwang PM. p53 regulates mitochondrial respiration. Science 312: 1650-1653, 2006. (Pubitemid 43902663)
114. McCarthy SM, Bove PF, Matthews DE, Akaike T, and van der Vliet A. Nitric oxide regulation of MMP-9 activation and its relationship to modifications of the cysteine switch. Biochemistry 47: 5832-5840, 2008. (Pubitemid 351747062)
115. McCrea PD, Gu D, and Balda MS. Junctional music that the nucleus hears: Cell-cell contact signaling and the modulation of gene activity. Cold Spring Harb Perspect Biol 1: a002923, 2009.
116. Meli DN, Christen S, and Leib SL. Matrix metalloproteinase-9 in pneumococcal meningitis: Activation via an oxidative pathway. J Infect Dis 187: 1411-1415, 2003. (Pubitemid 36549686)
117. Mertsch K, Blasig I, and Grune T. 4-Hydroxynonenal impairs the permeability of an in vitro rat blood-brain barrier. Neurosci Lett 314: 135-138, 2001. (Pubitemid 33043785)
118. Michiels C, Minet E, Mottet D, and Raes M. Regulation of gene expression by oxygen: NF-kappaB and HIF-1, two extremes. Free Radic Biol Med 33: 1231-1242, 2002. (Pubitemid 35246591)
119. Minami M, Katayama T, and Satoh M. Brain cytokines and chemokines: Roles in ischemic injury and pain. J Pharmacol Sci 100: 461-470, 2006. (Pubitemid 44609536)
120. Minami M and Satoh M. Chemokines and their receptors in the brain: Pathophysiological roles in ischemic brain injury. Life Sci 74: 321-327, 2003. (Pubitemid 37357063)
121. Mizutani H, Tada-Oikawa S, Hiraku Y, Kojima M, and Kawanishi S. Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide. Life Sci 76: 1439-1453, 2005. (Pubitemid 40164773)
122. Morita-Fujimura Y, Fujimura M, Gasche Y, Copin JC, and Chan PH. Overexpression of copper and zinc superoxide dismutase in transgenic mice prevents the induction and activation of matrix metalloproteinases after cold injuryinduced brain trauma. J Cereb Blood Flow Metab 20: 130-138, 2000. (Pubitemid 30019838)
123. Murakami T, Felinski EA, and Antonetti DA. Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability. J Biol Chem 284: 21036-21046, 2009.
124. Nag S, Picard P, and Stewart DJ. Expression of nitric oxide synthases and nitrotyrosine during blood-brain barrier breakdown and repair after cold injury. Lab Invest 81: 41-49, 2001. (Pubitemid 32108638)
125. Nagyoszi P, Wilhelm I, Farkas AE, Fazakas C, Dung NT, Hasko J, and Krizbai IA. Expression and regulation of tolllike receptors in cerebral endothelial cells. Neurochem Int 57: 556-564, 2010.
126. Nishino T. The conversion of xanthine dehydrogenase to xanthine oxidase and the role of the enzyme in reperfusion injury. J Biochem 116: 1-6, 1994. (Pubitemid 24230774)
127. Nishino T, Okamoto K, Eger BT, Pai EF, and Nishino T. Mammalian xanthine oxidoreductase: Mechanism of transition from xanthine dehydrogenase to xanthine oxidase. FEBS J 275: 3278-3289, 2008. (Pubitemid 351813552)
128. Novo E and Parola M. Redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis Tissue Repair 1: 5, 2008.
129. Oesterreich S, Lee AV, Sullivan TM, Samuel SK, Davie JR, and Fuqua SA. Novel nuclear matrix protein HET binds to and influences activity of the HSP27 promoter in human breast cancer cells. J Cell Biochem 67: 275-286, 1997. (Pubitemid 27431172)
130. Overgaard CE, Daugherty BL, Mitchell LA, and Koval M. Claudins: control of barrier function and regulation in response to oxidant stress. Antioxid Redox Signal 15: 1179-1193, 2011.
131. Pacher P, Nivorozhkin A, and Szabo C. Therapeutic effects of xanthine oxidase inhibitors: Renaissance half a century after the discovery of allopurinol. Pharmacol Rev 58: 87-114, 2006.
132. Panayiotidis M. Reactive oxygen species (ROS) in multistage carcinogenesis. Cancer Lett 266: 3-5, 2008.
133. Patenaude A, Murthy MR, AND Mirault ME. Emerging roles of thioredoxin cycle enzymes in the central nervous system. Cell Mol Life Sci 62: 1063-1080, 2005. (Pubitemid 40868526)
134. Phares TW, Fabis MJ, Brimer CM, Kean RB, AND Hooper DC. A peroxynitrite-dependent pathway is responsible for blood-brain barrier permeability changes during a central nervous system inflammatory response: TNF-alpha is neither necessary nor sufficient. J Immunol 178: 7334-7343, 2007. (Pubitemid 46847461)
135. Rabbani N and Thornalley PJ. Assay of 3-nitrotyrosine in tissues and body fluids by liquid chromatography with tandem mass spectrometric detection. Methods Enzymol 440: 337-359, 2008.
136. Ramana CV, Boldogh I, Izumi T, and Mitra S. Activation of apurinic/apyrimidinic endonuclease in human cells by reactive oxygen species and its correlation with their adaptive response to genotoxicity of free radicals. Proc Natl Acad Sci USA 95: 5061-5066, 1998. (Pubitemid 28208550)
137. Rao GM, Rao AV, Raja A, Rao S, and Rao A. Role of antioxidant enzymes in brain tumours. Clin Chim Acta 296: 203-212, 2000. (Pubitemid 30243152)
138. Rao R. Oxidative stress-induced disruption of epithelial and endothelial tight junctions. Front Biosci 13: 7210-7226, 2008.
139. Reijerkerk A, Kooij G, van der Pol SM, Khazen S, Dijkstra CD, and de Vries HE. Diapedesis of monocytes is associated with MMP-mediated occludin disappearance in brain endothelial cells. FASEB J 20: 2550-2552, 2006.
140. Ridnour LA, Windhausen AN, Isenberg JS, Yeung N, Thomas DD, Vitek MP, Roberts DD, and Wink DA. Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and-independent pathways. Proc Natl Acad Sci USA 104: 16898-16903, 2007. (Pubitemid 350210962)
141. Rosenberg GA. Matrix metalloproteinases in neuroinflammation. Glia 39: 279-291, 2002.
142. Rosenberg GA and Yang Y. Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia. Neurosurg Focus 22: E4, 2007.
143. Russo MT, De Luca G, Degan P, and Bignami M. Different DNA repair strategies to combat the threat from 8-oxoguanine. Mutat Res 614: 69-76, 2007. (Pubitemid 44909210)
144. Ryu JK and McLarnon JG. Minocycline or iNOS inhibition block 3-nitrotyrosine increases and blood-brain barrier leakiness in amyloid beta-peptide-injected rat hippocampus. Exp Neurol 198: 552-557, 2006.
145. Sarsour EH, Kumar MG, Chaudhuri L, Kalen AL, and Goswami PC. Redox control of the cell cycle in health and disease. Antioxid Redox Signal 11: 2985-3011, 2009.
146. Saunders NR, Ek CJ, Habgood MD, and Dziegielewska KM. Barriers in the brain: A renaissance? Trends Neurosci 31: 279-286, 2008.
147. Schmidt AM, Yan SD, Yan SF, and Stern DM. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 108: 949-955, 2001. (Pubitemid 32946067)
148. Schreibelt G, Kooij G, Reijerkerk A, van Doorn R, Gringhuis SI, van der Pol S, Weksler BB, Romero IA, Couraud PO, Piontek J, Blasig IE, Dijkstra CD, Ronken E, and de Vries HE. Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB J 21: 3666-3676, 2007. (Pubitemid 350075154)
149. Stadtman ER. Protein oxidation and aging. Free Radic Res 40: 1250-1258, 2006. (Pubitemid 44698274)
150. Stadtman ER and Levine RL. Free radical-mediated oxidation of free amino acids and amino acid residues in proteins. Amino Acids 25: 207-18, 2003. (Pubitemid 38043943)
151. Stadtman ER, Van Remmen H, Richardson A, Wehr NB, and Levine RL. Methionine oxidation and aging. Biochim Biophys Acta 1703: 135-140, 2005. (Pubitemid 40170436)
152. Stalker TJ, Wu J, Morgans A, Traxler EA, Wang L, Chatterjee MS, Lee D, Quertermous T, Hall RA, Hammer DA, Diamond SL, and Brass LF. Endothelial cell specific adhesion molecule (ESAM) localizes to platelet-platelet contacts and regulates thrombus formation in vivo. J Thromb Haemost 7: 1886-1896, 2009.
153. Steed E, Balda MS, and Matter K. Dynamics and functions of tight junctions. Trends Cell Biol 20: 142-149, 2010.
154. Sternlicht MD and Werb Z. How matrix metalloproteinases regulate cell
155. Sundaresan M, Yu ZX, Ferrans VJ, Sulciner DJ, Gutkind JS, Irani K, Goldschmidt-Clermont PJ, and Finkel T. Regulation of reactive-oxygen-species generation in fibroblasts by Rac1. Biochem J 318: 379-382, 1996. (Pubitemid 26305933)
156. Suyama K, Shapiro I, Guttman M, and Hazan RB. A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell 2: 301-314, 2002. (Pubitemid 41043964)
157. Svedin P, Hagberg H, Savman K, Zhu C, and Mallard C. Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia. J Neurosci 27: 1511-1518, 2007. (Pubitemid 46280068)
158. Swanson RA, Ying W, and Kauppinen TM. Astrocyte influences on ischemic neuronal death. Curr Mol Med 4: 193-205, 2004. (Pubitemid 38425914)
159. Szabo C, Ischiropoulos H, and Radi R. Peroxynitrite: Biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 6: 662-680, 2007. (Pubitemid 47207751)
160. Takenaga Y, Takagi N, Murotomi K, Tanonaka K, and Takeo S. Inhibition of Src activity decreases tyrosine phosphorylation of occludin in brain capillaries and attenuates increase in permeability of the blood-brain barrier after transient focal cerebral ischemia. J Cereb Blood Flow Metab 29: 1099-1108, 2009.
161. Tan KH, Harrington S, Purcell WM, and Hurst RD. Peroxynitrite mediates nitric oxide-induced blood-brain barrier damage. Neurochem Res 29: 579-587, 2004. (Pubitemid 38295008)
162. Tan S, Gelman S, Wheat JK, and Parks DA. Circulating xanthine oxidase in human ischemia reperfusion. South Med J 88: 479-482, 1995.
163. Tapia R, Huerta M, Islas S, Avila-Flores A, Lopez-Bayghen E, Weiske J, Huber O, and Gonzalez-Mariscal L. Zona occludens-2 inhibits cyclin D1 expression and cell proliferation and exhibits changes in localization along the cell cycle. Mol Biol Cell 20: 1102-1117, 2009.
164. Taylor CT and Cummins EP. The role of NF-kappaB in hypoxia-induced gene expression. Ann NY Acad Sci 1177: 178-184, 2009.
165. Tell G, Quadrifoglio F, Tiribelli C, and Kelley MR. The many functions of APE1/Ref-1: Not only a DNA repair enzyme. Antioxid Redox Signal 11: 601-620, 2009.
166. Tempfer H, Wagner A, Gehwolf R, Lehner C, Tauber M, Resch H, and Bauer HC. Perivascular cells of the supraspinatus tendon express both tendon-and stem cell-related markers. Histochem Cell Biol 131: 733-741, 2009.
167. Toda N, Ayajiki K, and Okamura T. Cerebral blood flow regulation by nitric oxide: Recent advances. Pharmacol Rev 61: 62-97, 2009.
168. Toyokuni S. Novel aspects of oxidative stress-associated carcinogenesis. Antioxid Redox Signal 8: 1373-1377, 2006. (Pubitemid 44192316)
169. Trachootham D, Lu W, Ogasawara MA, Nilsa RD, and Huang P. Redox regulation of cell survival. Antioxid Redox Signal 10: 1343-1374, 2008.
170. Traweger A, Fuchs R, Krizbai IA, Weiger TM, Bauer HC, and Bauer H. The tight junction protein ZO-2 localizes to the nucleus and interacts with the heterogeneous nuclear ribonucleoprotein scaffold attachment factor-B. J Biol Chem 278: 2692-2700, 2003. (Pubitemid 36801350)
171. Tsukita S, Furuse M, and Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2: 285-293, 2001. (Pubitemid 33676971)
172. Vafa O, Wade M, Kern S, Beeche M, Pandita TK, Hampton GM, and Wahl GM. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol Cell 9: 1031-1044, 2002. (Pubitemid 34626672)
173. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, and Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39: 44-84, 2007. (Pubitemid 44566469)
174. Vallet P, Charnay Y, Steger K, Ogier-Denis E, Kovari E, Herrmann F, Michel JP, and Szanto I. Neuronal expression of the NADPH oxidase NOX4, and its regulation in mouse experimental brain ischemia. Neuroscience 132: 233-238, 2005. (Pubitemid 40417898)
175. Van der Goes A, Wouters D, Van Der Pol SM, Huizinga R, Ronken E, Adamson P, Greenwood J, Dijkstra CD, and De Vries HE. Reactive oxygen species enhance the migration of monocytes across the blood-brain barrier in vitro. FASEB J 15: 1852-1854, 2001.
176. Vepa S, Scribner WM, Parinandi NL, English D, Garcia JG, and Natarajan V. Hydrogen peroxide stimulates tyrosine phosphorylation of focal adhesion kinase in vascular endothelial cells. Am J Physiol 277: L150-158, 1999. (Pubitemid 29356762)
177. Visse R and Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ Res 92: 827-839, 2003. (Pubitemid 36542523)
178. Wang JY, Wen LL, Huang YN, Chen YT, and Ku MC. Dual effects of antioxidants in neurodegeneration: Direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation. Curr Pharm Des 12: 3521-3533, 2006.
179. Wang X and Feuerstein GZ. Induced expression of adhesion molecules following focal brain ischemia. J Neurotrauma 12: 825-832, 1995.
180. Wang X, Yue TL, Barone FC, and Feuerstein GZ. Monocyte chemoattractant protein-1 messenger RNA expression in rat ischemic cortex. Stroke 26: 661-665; discussion 665-666, 1995.
181. Watts LT, Rathinam ML, Schenker S, and Henderson GI. Astrocytes protect neurons from ethanol-induced oxidative stress and apoptotic death. J Neurosci Res 80: 655-666, 2005. (Pubitemid 40896186)
182. Wegmann F, Ebnet K, Du Pasquier L, Vestweber D, and Butz S. Endothelial adhesion molecule ESAM binds directly to the multidomain adaptor MAGI-1 and recruits it to cell contacts. Exp Cell Res 300: 121-133, 2004. (Pubitemid 39286222)
183. Wegmann F, Petri B, Khandoga AG, Moser C, Khandoga A, Volkery S, Li H, Nasdala I, Brandau O, Fassler R, Butz S, Krombach F, and Vestweber D. ESAM supports neutrophil extravasation, activation of Rho, and VEGF-induced vascular permeability. J Exp Med 203: 1671-1677, 2006. (Pubitemid 44036272)
184. Wiernsperger NF. Oxidative stress: The special case of diabetes. Biofactors 19: 11-18, 2003. (Pubitemid 38073140)
185. Winkler F, Koedel U, Kastenbauer S, and Pfister HW. Differential expression of nitric oxide synthases in bacterial meningitis: Role of the inducible isoform for blood-brain barrier breakdown. J Infect Dis 183: 1749-1759, 2001. (Pubitemid 32523237)
186. Wolburg H, Wolburg-Buchholz K, Kraus J, Rascher-Eggstein G, Liebner S, Hamm S, Duffner F, Grote EH, Risau W, and Engelhardt B. Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme. Acta Neuropathol 105: 586-592, 2003. (Pubitemid 36798859)
187. Wong CH and Crack PJ. Modulation of neuro-inflammation and vascular response by oxidative stress following cerebral ischemia-reperfusion injury. Curr Med Chem 15: 1-14, 2008. (Pubitemid 351234624)
188. Yang Y, Estrada EY, Thompson JF, Liu W, and Rosenberg GA. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab 27: 697-709, 2007. (Pubitemid 46474608)
189. Yemisci M, Gursoy-Ozdemir Y, Vural A, Can A, Topalkara K, and Dalkara T. Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nat Med 15: 1031-1037, 2009.
190. Yilmaz G and Granger DN. Leukocyte recruitment and ischemic brain injury. Neuromolecular Med 12: 193-204, 2010.
191. Zhang C, Xu X, Potter BJ, Wang W, Kuo L, Michael L, Bagby GJ, and Chilian WM. TNF-alpha contributes to endothelial dysfunction in ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol 26: 475-480, 2006.
192. Zhao BQ, Wang S, Kim HY, Storrie H, Rosen BR, Mooney DJ, Wang X, and Lo EH. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med 12: 441-445, 2006.
193. Zhao J, Kobori N, Aronowski J, and Dash PK. Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents. Neurosci Lett 393: 108-112, 2006. (Pubitemid 41821089)
194. Zhao J, Moore AN, Redell JB, and Dash PK. Enhancing expression of Nrf2-driven genes protects the blood brain barrier after brain injury. J Neurosci 27: 10240-10248, 2007. (Pubitemid 47450456)
195. Zhao X and Benveniste EN. Transcriptional activation of human matrix metalloproteinase-9 gene expression by multiple co-activators. J Mol Biol 383: 945-956, 2008.
196. Zmijewski JW, Landar A, Watanabe N, Dickinson DA, Noguchi N, and Darley-Usmar VM. Cell signalling by oxidized lipids and the role of reactive oxygen species in the endothelium. Biochem Soc Trans 33: 1385-1389, 2005. (Pubitemid 41779694)